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Enhancers are distal regulatory sequences that control gene expression in development. Ørom et al. now
report in Cell that some long noncoding RNAs have functional properties of enhancers. Known enhancers
are also transcribed in cells in which they are active, suggesting that noncoding RNAs are integral to
enhancer action.There are three signature features of gene
regulation that are essential to the control
of development and cellular differentia-
tion in animals: epigenetic modulation of
the organization of chromatin, alternative
splicing, and enhancers. While much
remains to be learned about all three,
enhancers are the most enigmatic.
Enhancers are segments of genomic
regulatory sequences that act regionally,
but often at some distance from their
targets, to control the spatial and temporal
activation of specific genes during devel-
opment (for recent review, see Levine,
2010). They appear to be comprised of
complex clusters of binding sites for tran-
scription and related regulatory factors,
including the histone acetyltransferase
‘‘coactivator’’ p300 and its partner CBP,
whichhavebeenused to identify enhancer
locations in genome-wide ChIP-se-
quencing studies (see e.g., Kim et al.,
2010). There is also good evidence to
suggest that the mechanism of enhancer
action involves chromatin looping to bring
these factors into direct physical contact
with their target promoters (Levine,
2010), although the biochemical mecha-
nism by which this might selectively occur
is unknown.
In a recent issue of Cell, Ørom et al.
(2010) report that a number of long inter-
genic noncoding RNAs (lincRNAs) have
properties reminiscent of enhancers.
They defined a set of 2,200 human loci
encoding over 3,000 lincRNAs (including
splice variants) that range from 0.1
to 9 kb in length, are distal to known
protein-coding genes, and have little
or no protein-coding potential. These
lincRNAs display chromatin signatures of
expressed genes, as well as p300 and
CBP occupancy. Intriguingly, p300 andCBP occupancy are also observed in
surrounding protein-coding genes, sug-
gesting that these proteins may have
functions beyond simply marking en-
hancers or that many protein-coding
transcripts may also have enhancer-like
regulatory functions, an interesting
possibility that has yet to be tested but
which is presaged by the curious
phenomenon of ‘‘transinduction’’ (Ashe
et al., 1997). Most of these RNAs can
be detected in one or other tissue or
cell type, and many are differentially ex-
pressed, as has been previously reported
for many other long noncoding RNAs
(see Amaral and Mattick, 2008 and refer-
ences therein).
The key finding of Ørom et al. (2010)
is that the depletion of seven of these
lincRNAs (out of 12 tested) by siRNA-
mediated knockdown resulted in a con-
comitant decrease in the expression of
some, but not other, nearby (within a
window of 300 kb) protein-coding genes.
In one case, studied in detail, the lincRNA
knockdown was phenocopied by the
knockdown of one of the affected pro-
tein-coding transcripts, suggesting bio-
logical relevance for the relationship
between lincRNA and associated mRNA
expression. Importantly, Ørom et al. also
showed that, characteristic of enhancers,
the sequence encoding the lincRNA
could activate a proximal heterologous
promoter in a reporter construct, without
itself having promoter activity, and that
this activation was independent of the
orientation of the sequence. The activa-
tion of the heterologous promoter was
also abrogated by siRNA-mediated
knockdown of the RNA and by modifica-
tions that interfered with its sequence,
but not its transcription.Developmental Cell 19The seven lincRNAs studied by Ørom
et al. stand in contrast to the well-charac-
terized noncoding RNA XIST involved in
X chromosome dosage compensation
and others involved in parental imprinting,
which have repressive functions and (like
many other long noncoding RNAs) are
associated with repressive chromatin-
modifying complexes (Khalil et al., 2009;
Mattick et al., 2009). However, there are
also others, including antisense RNAs,
that have been shown to have activating
functions and to be associated with acti-
vated chromatin (see Mattick et al., 2009).
The lincRNA loci defined by Ørom et al.
have characteristics that are similar to but
differ in some respects from other cata-
logs of noncoding transcripts defined by
different criteria (Khalil et al., 2009;
Kim et al., 2010), whose functional reper-
toires may well overlap. These catalogs
are, in fact, all very restricted subsets of
the tens if not hundreds of thousands of
intergenic, intronic, overlapping, and
antisense noncoding RNAs that are ex-
pressed from mammalian genomes
(Amaral and Mattick, 2008), many of
which may also function as ‘‘activating’’
or ‘‘repressive’’ RNAs.
Are the loci that produce such RNAs
true enhancers and does enhancer func-
tion involve RNA? This seems highly likely.
While not widely appreciated, many (if not
all) enhancers are transcribed into non-
coding RNAs in the cells in which they
are active. Indeed, this has been shown
for many enhancers, including those in
the iconic globin locus control region
(Ashe et al., 1997) and those that are
active in neuronal cells, whose expression
also correlates with adjacent protein-
coding genes (Kim et al., 2010). However,
the expression of these enhancer-derived, October 19, 2010 ª2010 Elsevier Inc. 485
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as a by-product of (regulated) transcrip-
tion through the locus to open it up for
the binding of regulatory proteins, a some-
what circular logic. The alternative, given
strong support by the findings of Ørom
et al., as well as Kim et al. (2010), is that
the transcribed noncoding RNAs are inte-
gral to enhancer action.
The involvement of RNA could provide
a three-dimensional platform to recruit
and organize appropriate transcription
factors and chromatin modification com-
plexes, many of which contain domains
that bind RNA or higher-order structures
containing RNA (Mattick et al., 2009).
The RNA could also provide a con-
comitant mechanism to bring these
complexes into contact with specific pro-
moters through sequence-specific inter-
actions (Koziol and Rinn, 2010). In this
context, the distinction between cis- and
trans-regulation becomes blurred, as
enhancers can be quite distal to their
targets. However, this may also be ratio-
nalized by the involvement of bridging
RNAs. Intriguingly, many enhancers are
among the most highly constrained
sequences in the mammalian genome
(Pennacchio et al., 2006), some with
100% sequence identity in segments of
200 bp or more in different mammals,
which is otherwise observed only in ribo-
somal RNA. This is difficult to reconcile
with clusters of transcription factor
binding motifs, which are known to
have plastic consensus sequences and
arrangements in promoters. Alternatively,486 Developmental Cell 19, October 19, 2010the strict conservation of these noncoding
regulatory elements may be because of
complex RNA-DNA-protein interactions
that are required for their function.
Such noncoding RNAs may also
provide a mechanistic explanation for
the equally enigmatic phenomenon of
transvection, which has been well studied
in Drosophila but also occurs in mam-
mals. Transvection refers to genetic com-
plementation between heterozygotic
alleles with disabling mutations in regula-
tory sequences on one chromosome
(which are presumed to be cis-acting but
are differentially transcribed to produce
long noncoding RNAs) and adjacent
protein-coding sequences on the sister
chromosome. This complementation ap-
pears to require chromosomal pairing
but also to involve a trans-acting interme-
diate (see Mattick and Gagen, 2001 and
references therein). It is possible that
regulatory element-encoded RNAs
mediate such chromosomal interactions.
The central question of whether long
noncoding RNAs are integral to enhancer
function may be resolved by examining
whether the function of well-character-
ized enhancers can be perturbed by
siRNA (or other RNA-directed) knock-
down approaches directed at the
enhancer-derived RNAs, preferably
in vivo, and by identifying the mechanism
by which these RNAs mediate enhancer
activity. Experiments along these lines
would provide direct evidence that the
RNA transcribed from the enhancer is
not simply a by-product of the processª2010 Elsevier Inc.but central to it. If this proves to be the
case, it would revolutionize the concep-
tual framework for understanding the
mechanism of enhancer action and the
importance of the vast numbers of non-
coding RNAs that are differentially ex-
pressed from animal genomes during
development.
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